Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HVCN1 blockers(hydrogen voltage gated channel 1 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H13ClN2O2S |
InChIKeyIYIITGYYTBUPTI-UHFFFAOYSA-N |
CAS Registry132858-26-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory pain | Preclinical | CN | 03 Feb 2022 | |
Inflammatory pain | Preclinical | CN | 03 Feb 2022 |